Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
Search
Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
More
Search
Accredited Duchenne Centers (ADC) Aims to Provide Uniform and Up-to-date Care for All People Living with Duchenne Muscular Dystrophy
Editorials
DMD Warrior
-
The World Duchenne Organization (WDO) launched the international Accredited Duchenne Centers (ADC) Program. The ADC Program's goal is to...
RGX-202 Gene Therapy Phase 3 Clinical Trial Begins
Research
DMD Warrior
-
RGX-202, one of the alternative gene therapy candidates developed for Duchenne Muscular Dystrophy, continues to accept applications from candidate...
Entrada Therapeutics Begins Clinical Trials in Europe for Exon 44 and Exon 45 Skipping Therapies
Research
DMD Warrior
-
Entrada Therapeutics has officially launched clinical trials in Europe for its innovative exon skipping therapies targeting Exon 44 and...
Wellcome Trust Donates £10 Million to Treat Rare Diseases
Editorials
DMD Warrior
-
Edgewise Therapeutics Reports Positive Results on Sevasemten Program for Becker and Duchenne Muscular Dystrophies
Press Releases
DMD Warrior
-
Precision BioSciences Receives FDA Rare Pediatric Disease Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy
Press Releases
DMD Warrior
-
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
Press Releases
DMD Warrior
-
Load more
